These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8447689)

  • 1. Plasma viscosity in giant cell arteritis as a predictor of disease activity.
    Gudmundsson M; Nordborg E; Bengtsson BA; Bjelle A
    Ann Rheum Dis; 1993 Feb; 52(2):104-9. PubMed ID: 8447689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase reactants in the initial phase of giant cell arteritis.
    Andersson R; Malmvall BE; Bengtsson BA
    Acta Med Scand; 1986; 220(4):365-7. PubMed ID: 3099544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
    Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?
    Brittain GP; McIlwaine GG; Bell JA; Gibson JM
    Br J Ophthalmol; 1991 Nov; 75(11):656-9. PubMed ID: 1751458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma viscosity in giant cell arteritis.
    Finke C; Schroeter J; Kalus U; Ploner CJ
    Eur Neurol; 2011; 66(3):159-64. PubMed ID: 21894018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
    Pountain GD; Calvin J; Hazleman BL
    Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma viscosity and the diagnosis of giant cell arteritis.
    Orrell RW; Johnson MH
    Br J Clin Pract; 1993; 47(2):71-2. PubMed ID: 8334065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
    Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schulze-Koops H; Schett G; Spiera R; Unizony SH; Collinson N
    Arthritis Rheumatol; 2019 Aug; 71(8):1329-1338. PubMed ID: 30835950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
    Park JR; Jones JG; Hazleman BL
    Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Temporal arteritis: do not rely on the erythrocyte sedimentation rate].
    Bernelot Moens HJ
    Ned Tijdschr Geneeskd; 2015; 159():A9196. PubMed ID: 26332818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.
    Liozon E; Parreau S; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Rheumatol Int; 2023 Jul; 43(7):1323-1331. PubMed ID: 37024620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
    Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature.
    Zweegman S; Makkink B; Stehouwer CD
    Neth J Med; 1993 Apr; 42(3-4):128-31. PubMed ID: 8316325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection.
    Ishak R; Hassan K
    Malays J Pathol; 1989 Aug; 11():29-31. PubMed ID: 2632997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.
    Hayreh SS; Zimmerman B
    Ophthalmologica; 2003; 217(4):239-59. PubMed ID: 12792130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
    Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder.
    Cheema MR; Ismaeel SM
    Clin Interv Aging; 2016; 11():185-8. PubMed ID: 26966355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.